SCYNEXIS logo

SCYNEXIS

SCYX | NASDAQ
Chart Builder DCF Calculator
$2.91
-$0.30 (-9.35%)
At close: Nov 16, 2026, 4:00 PM ET
$2.90
-$0.01 (-0.34%)
After-hours: Nov 16, 2026, 7:30 PM ET
-9.35%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
41.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #475/1021 (Top 47%)

Key Statistics

Market Data

Market Cap $34.46M
1D Range
2.87 3.05
52W Range
2.87 8.88

Valuation (TTM)

PE -2.49
PB 0.58
EV/EBITDA 0.95

Valuation (NTM)

Forward PE 1.21
Forward PEG -0.11
Price Target $33.00
Loading financial charts...

Profile

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal...

Sector Healthcare
Employees 18
IPO Date May 2, 2014
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.71
Miss -77.50%
REV
$130.5K
Beat 0.00%
Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$33.00
Upside
+1034.02%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.